SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-241375"
 

Search: onr:"swepub:oai:DiVA.org:uu-241375" > Mechanistic Modelin...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes : A Proteomics-Informed Bottom-Up Approach

Vildhede, Anna (author)
Uppsala universitet,Institutionen för farmaci
Mateus, André (author)
Uppsala universitet,Institutionen för farmaci
Khan, Elin K. (author)
Uppsala universitet,Institutionen för farmaci
show more...
Lai, Yurong (author)
Bristol Myers Squibb Co, Princeton, NJ USA
Karlgren, Maria (author)
Uppsala universitet,Institutionen för farmaci
Artursson, Per (author)
Uppsala universitet,Institutionen för farmaci,Science for Life Laboratory, SciLifeLab
Kjellsson, Maria C. (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap
show less...
 (creator_code:org_t)
2016-02-03
2016
English.
In: Drug Metabolism And Disposition. - : American Society for Pharmacology & Experimental Therapeutics (ASPET). - 0090-9556 .- 1521-009X. ; 44:4, s. 505-516
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Isolated human hepatocytes are commonly used to predict transporter-mediated clearance in vivo. Such predictions, however, do not provide estimations of transporter contributions and consequently do not allow predictions of the outcome resulting from a change in the activity of a certain transporter, e.g., by inhibition or a genetic variant with reduced function. Pitavastatin is a drug that is heavily dependent on hepatic transporters for its elimination and it is mainly excreted as unchanged drug in the bile. For this reason, pitavastatin was used as a model drug to demonstrate the applicability of a bottom-up approach to predict transporter-mediated disposition in sandwich-cultured human hepatocytes (SCHH), allowing for the estimation of transporter contributions. Transport experiments in transfected HEK293 cells and inverted membrane vesicles overexpressing each of the relevant transport proteins were used to generate parameter estimates for the mechanistic model. By adjusting for differences in transporter abundance between the in vitro systems and individual SCHH batches, the model successfully predicted time profiles of medium and intracellular accumulation. Our predictions of pitavastatin bile accumulation could, however, not be confirmed due to a very low biliary excretion of pitavastatin in relation to the hepatic uptake in our SCHH. This study is, to our knowledge, the first to successfully simulate transporter-mediated processes in a complex system such as SCHH at the level of individual transport proteins using a bottom-up approach.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Keyword

pitavastatin
SCHH
hepatocytes
drug transport
OATP
NTCP
hepatic uptake
Pgp
BCRP
MRP2
MRP3
Biopharmaceutics
Biofarmaci

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view